invivo mab rat igg2a isotype control antibody clone 2a3 (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
90
Structured Review
Bio X Cell
invivo mab rat igg2a isotype control antibody clone 2a3
Invivo Mab Rat Igg2a Isotype Control Antibody Clone 2a3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igg2a+isotype+control+2a3+antibody/anti+cd4+gk1+5/pmc12255530-46-0-10
Average 90 stars, based on 1 article reviews
Invivo Mab Rat Igg2a Isotype Control Antibody Clone 2a3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igg2a+isotype+control+2a3+antibody/anti+cd4+gk1+5/pmc12255530-46-0-10
Average 90 stars, based on 1 article reviews
invivo mab rat igg2a isotype control antibody clone 2a3 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Control:Article Title: Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation Article Snippet: .. Neutrophil depletion was achieved by intraperitoneal injections of anti-mouse Ly6G antibody (clone 1A8, 50 μg/mouse, #BE0075-1, BioXcell) or Article Title: Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Article Snippet: PaB670129 was synthesized according to US20180305450A1 by RD- Biotech. .. Anti- mouse PD1 (clone RMP1- 14, cat. BE0146, BioXCell, RRID: AB_10949053), Article Title: ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2. Article Snippet: .. Experimental Section/Methods Reagents and antibodies: The compounds used in this study are listed below with their sources: Y-27632 (HY-10583, MedChemExpress), fasudil (HY-10341, MedChemExpress), LY-2090314 (HY-16294, MedChemExpress), MG-132 (HY-13259, MedChemExpress), human recombinant IL-2 (200-02-50UG, Peprotech), anti-mouse PD-L1 (BE0101, BioXCell), and Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. After 7 days, mice were intraperitoneally treated with either an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, BioXcell, Cat# BP0273) or a Article Title: Targeting Mettl8-Tcf1 axis promotes CD8 + T PEX differentiation and antitumor immunity Article Snippet: .. Anti–PD-1 treatments involved i.p. administration of 200 μg per mouse of anti–PD-1 antibody (clone RMP1-14, cat. no. A2122; Selleckchem) or Article Title: Lymphocyte Antigen 6G Mediates Vagotomy‐Associated Reduction in Body Weight Article Snippet: Nuclei count was measured in ImageJ FIJI by threshold and particles counting, then normalized by the following equation: Non‐adipocyte nuclei % = ((Total nuclei count—Adipocyte count)/Total nuclei count) × 100%. .. To ligate Ly6G surface epitopes, male C57BL/6 mice were intraperitoneally injected with InVivo Mab anti‐mouse Ly6G (100 ug/100 uL) (Bioxcell, #BE0075) or for Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. Beginning on day 7 post-surgery, they were then administered an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, sourced from BioXcell, Cat# BP0273) or a Article Title: Lymphocyte Antigen
Article Snippet: Nuclei count was measured in ImageJ FIJI by threshold and particles counting, then normalized by the following equation: Non- adipocyte nuclei % = ((Total nuclei count—Adipocyte count)/Total nuclei count) × 100%. .. To ligate Ly6G surface epitopes, male C57BL/6 mice were intraperitoneally injected with InVivo Mab anti- mouse Ly6G (100 ug/100 uL) (Bioxcell, #BE0075) or for Injection:Article Title: Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation Article Snippet: .. Neutrophil depletion was achieved by intraperitoneal injections of anti-mouse Ly6G antibody (clone 1A8, 50 μg/mouse, #BE0075-1, BioXcell) or Article Title: Lymphocyte Antigen 6G Mediates Vagotomy‐Associated Reduction in Body Weight Article Snippet: Nuclei count was measured in ImageJ FIJI by threshold and particles counting, then normalized by the following equation: Non‐adipocyte nuclei % = ((Total nuclei count—Adipocyte count)/Total nuclei count) × 100%. .. To ligate Ly6G surface epitopes, male C57BL/6 mice were intraperitoneally injected with InVivo Mab anti‐mouse Ly6G (100 ug/100 uL) (Bioxcell, #BE0075) or for Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. Beginning on day 7 post-surgery, they were then administered an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, sourced from BioXcell, Cat# BP0273) or a Article Title: Lymphocyte Antigen
Article Snippet: Nuclei count was measured in ImageJ FIJI by threshold and particles counting, then normalized by the following equation: Non- adipocyte nuclei % = ((Total nuclei count—Adipocyte count)/Total nuclei count) × 100%. .. To ligate Ly6G surface epitopes, male C57BL/6 mice were intraperitoneally injected with InVivo Mab anti- mouse Ly6G (100 ug/100 uL) (Bioxcell, #BE0075) or for Synthesized:Article Title: Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Article Snippet: PaB670129 was synthesized according to US20180305450A1 by RD- Biotech. .. Anti- mouse PD1 (clone RMP1- 14, cat. BE0146, BioXCell, RRID: AB_10949053), Recombinant:Article Title: ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2. Article Snippet: .. Experimental Section/Methods Reagents and antibodies: The compounds used in this study are listed below with their sources: Y-27632 (HY-10583, MedChemExpress), fasudil (HY-10341, MedChemExpress), LY-2090314 (HY-16294, MedChemExpress), MG-132 (HY-13259, MedChemExpress), human recombinant IL-2 (200-02-50UG, Peprotech), anti-mouse PD-L1 (BE0101, BioXCell), and In Vivo:Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. After 7 days, mice were intraperitoneally treated with either an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, BioXcell, Cat# BP0273) or a Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. Beginning on day 7 post-surgery, they were then administered an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, sourced from BioXcell, Cat# BP0273) or a Blocking Assay:Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. After 7 days, mice were intraperitoneally treated with either an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, BioXcell, Cat# BP0273) or a Article Title: Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy Article Snippet: .. Beginning on day 7 post-surgery, they were then administered an in vivo blocking antibody against mouse PD-1 (Clone: 29F.1A2, sourced from BioXcell, Cat# BP0273) or a |